Department of Physical Medicine and Rehabilitation, Physical Therapy Program, University of Colorado Denver, Aurora, Colorado 80045, USA.
J Neurol Phys Ther. 2010 Dec;34(4):182-92. doi: 10.1097/NPT.0b013e3181fd1b8d.
Individuals with Parkinson disease (PD) experience a range of deficits of body systems and activities. A clinical test is needed that is reliable, valid, applicable to physical therapist practice, and appropriate for use in early and mid-stages of the disease. PROFILE PD is one such scale, consisting of 24 items that would typically be assessed during the physical therapist's examination and evaluation of individuals with PD. The purpose of this article is to report on clinimetric properties of the PROFILE PD and to make the test available for use.
Interrater reliability was determined using the intraclass correlation coefficient. Construct validity was determined by comparing scores on the PROFILE PD with the gold standard (Unified Parkinson's Disease Rating Scale [UPDRS]) as well as scales of physical activity and participation. Construct validity and structure of the PROFILE PD were further examined using exploratory factor analysis using principal component analysis with Promax rotation that allows a correlated factor structure.
Interrater reliability of the PROFILE PD was high (ICC = 0.97). Construct validity was demonstrated with the UPDRS (r = 0.86, P < 0.0001), Schwab & England Activities of Daily Living Scale (S&E) (r = -0.83, P < 0.0001), and Continuous Scale Physical Functional Performance test (r = -0.62, P < 0.0001). Principal component analysis demonstrated that the test comprises a single scale.
The PROFILE PD is a reliable and valid scale that can be used to quantify alterations in body systems and activity of individuals in early and mid-stages of PD. Use of the scale can provide an overall summary of the impact of PD on body systems and activities.
帕金森病(PD)患者会出现一系列身体系统和活动的缺陷。需要一种可靠、有效、适用于物理治疗师实践、并适用于疾病早期和中期的临床测试。PROFILE PD 就是这样一种量表,由 24 个项目组成,通常在物理治疗师对 PD 患者进行检查和评估时进行评估。本文的目的是报告 PROFILE PD 的临床计量学特性,并使其可供使用。
使用组内相关系数确定组内信度。通过将 PROFILE PD 的评分与金标准(统一帕金森病评定量表[UPDRS])以及身体活动和参与量表进行比较来确定结构效度。使用主成分分析和 Promax 旋转的探索性因子分析进一步检查 PROFILE PD 的结构效度和结构,允许相关因子结构。
PROFILE PD 的组内信度很高(ICC = 0.97)。与 UPDRS(r = 0.86,P < 0.0001)、施瓦布和英格兰日常生活活动量表(S&E)(r = -0.83,P < 0.0001)和连续量表身体功能表现测试(r = -0.62,P < 0.0001)的相关性证明了结构效度。主成分分析表明,该测试由一个单一的量表组成。
PROFILE PD 是一种可靠且有效的量表,可用于量化 PD 早期和中期个体身体系统和活动的改变。使用该量表可以提供 PD 对身体系统和活动影响的总体概述。